Alpha-1 Antitrypsin Deficiency: Home Therapy

While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by...

Full description

Bibliographic Details
Main Authors: Anna Annunziata, Maurizia Lanza, Antonietta Coppola, Paolo Andreozzi, Sara Spinelli, Giuseppe Fiorentino
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.575402/full
id doaj-1a0946e1e6414b9b87b83c4beba90b98
record_format Article
spelling doaj-1a0946e1e6414b9b87b83c4beba90b982021-04-15T08:28:34ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-04-011210.3389/fphar.2021.575402575402Alpha-1 Antitrypsin Deficiency: Home TherapyAnna Annunziata0Maurizia Lanza1Antonietta Coppola2Paolo Andreozzi3Sara Spinelli4Giuseppe Fiorentino5Department of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyGastroenterology Unit, Marcianise Hospital, Caserta, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyWhile available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program.https://www.frontiersin.org/articles/10.3389/fphar.2021.575402/fullalpha-1 antitrypsin (A1AT)home therapyaugmentation therapyQOL scoreSARSCoV-2
collection DOAJ
language English
format Article
sources DOAJ
author Anna Annunziata
Maurizia Lanza
Antonietta Coppola
Paolo Andreozzi
Sara Spinelli
Giuseppe Fiorentino
spellingShingle Anna Annunziata
Maurizia Lanza
Antonietta Coppola
Paolo Andreozzi
Sara Spinelli
Giuseppe Fiorentino
Alpha-1 Antitrypsin Deficiency: Home Therapy
Frontiers in Pharmacology
alpha-1 antitrypsin (A1AT)
home therapy
augmentation therapy
QOL score
SARS
CoV-2
author_facet Anna Annunziata
Maurizia Lanza
Antonietta Coppola
Paolo Andreozzi
Sara Spinelli
Giuseppe Fiorentino
author_sort Anna Annunziata
title Alpha-1 Antitrypsin Deficiency: Home Therapy
title_short Alpha-1 Antitrypsin Deficiency: Home Therapy
title_full Alpha-1 Antitrypsin Deficiency: Home Therapy
title_fullStr Alpha-1 Antitrypsin Deficiency: Home Therapy
title_full_unstemmed Alpha-1 Antitrypsin Deficiency: Home Therapy
title_sort alpha-1 antitrypsin deficiency: home therapy
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-04-01
description While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program.
topic alpha-1 antitrypsin (A1AT)
home therapy
augmentation therapy
QOL score
SARS
CoV-2
url https://www.frontiersin.org/articles/10.3389/fphar.2021.575402/full
work_keys_str_mv AT annaannunziata alpha1antitrypsindeficiencyhometherapy
AT maurizialanza alpha1antitrypsindeficiencyhometherapy
AT antoniettacoppola alpha1antitrypsindeficiencyhometherapy
AT paoloandreozzi alpha1antitrypsindeficiencyhometherapy
AT saraspinelli alpha1antitrypsindeficiencyhometherapy
AT giuseppefiorentino alpha1antitrypsindeficiencyhometherapy
_version_ 1721526392857821184